CDSCO UID IMP/IVD/2022/000360_c7e21e1429ed76d72f9b7878e6bf5410_3a191d6c336652a536bc4c15f0425b17LIAISON® Q.S.E.T. Device Plus
- UID
- IMP/IVD/2022/000360_c7e21e1429ed76d72f9b7878e6bf5410_3a191d6c336652a536bc4c15f0425b17
- Device class
- Class A
- Brand name
- LIAISON® Q.S.E.T. Device Plus
- License holder
- Diasorin Healthcare India Pvt. Ltd.
- Approving authority
- CDSCO
- Product information
- The LIAISON® Q.S.E.T. Device Plus (LIAISON® Q.S.E.T. Device Plus) is intended for use in the preparation of human stool specimens for testing in designated stool assays. The device is intended for in vitro diagnostic use in a professional laboratory setting on the automated LIAISON® Analyzer family.
LIAISON® Q.S.E.T. Device Plus is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2022/000360_c7e21e1429ed76d72f9b7878e6bf5410_3a191d6c336652a536bc4c15f0425b17. This device is marketed under the brand name LIAISON® Q.S.E.T. Device Plus. The license holder is Diasorin Healthcare India Pvt. Ltd., and it is classified as Device Class Class A. The approving authority is CDSCO.
This page provides the facts attached to this CDSCO registry row. Other records from the same license holder are available through the database search link without adding aggregation queries to this page. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.